Casdin Capital, LLC

10% Owner
Casdin Capital, LLC
$693,482,000.00
%
COMPANY
SHARES
NET TOTAL
16.93%
ALNYLAM PHARMACEUTICALS INC
805,000
$117,409,000.00
15.07%
BIOLIFE SOLUTIONS INC
7,566,292
$104,490,000.00
9.83%
RELAY THERAPEUTICS INC
4,068,574
$68,149,000.00
8.38%
BLUEPRINT MEDICINES CORP
1,150,000
$58,087,000.00
7.50%
FATE THERAPEUTICS INC
2,100,000
$52,038,000.00
7.03%
SAREPTA THERAPEUTICS INC
650,000
$48,724,000.00
6.66%
REVOLUTION MEDICINES INC
2,370,000
$46,191,000.00
6.37%
DENALI THERAPEUTICS INC
1,500,000
$44,145,000.00
3.69%
GLOBAL BLOOD THERAPEUTICS IN
800,000
$25,560,000.00
2.56%
EXACT SCIENCES CORP
450,000
$17,726,000.00
2.52%
TWIST BIOSCIENCE CORP
500,000
$17,480,000.00
2.51%
AGIOS PHARMACEUTICALS INC
785,000
$17,403,000.00
2.09%
BEAM THERAPEUTICS INC
375,000
$14,516,000.00
1.59%
GUARDANT HEALTH INC
272,500
$10,993,000.00
1.55%
KARUNA THERAPEUTICS INC
85,000
$10,753,000.00
1.15%
ABCELLERA BIOLOGICS INC
750,000
$7,988,000.00
0.94%
MIRATI THERAPEUTICS INC
97,000
$6,512,000.00
0.64%
CELLDEX THERAPEUTICS INC NEW
165,000
$4,448,000.00
0.62%
PMV PHARMACEUTICALS INC
300,000
$4,275,000.00
0.60%
SANGAMO THERAPEUTICS INC
1,000,000
$4,140,000.00
0.56%
4D MOLECULAR THERAPEUTICS IN
555,455
$3,877,000.00
0.42%
MAGENTA THERAPEUTICS INC
2,415,000
$2,898,000.00
0.39%
ORIC PHARMACEUTICALS INC
601,515
$2,695,000.00
0.37%
INVITAE CORP
1,038,388
$2,534,000.00
0.07%
KRONOS BIO INC
123,839
$451,000.00